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Abstract
Background: Experimental studies in humans have yielded evidence that adaptive immune function, including the
production of antigen-specific antibodies, is distinctly impaired when sleep is deprived at the time of first antigen
exposure. Here we examined the effects of a regular 24- hour sleep-wake cycle (including 8 hours of nocturnal
sleep) and a 24-hour period of continuous wakefulness on the 7-week antibody production in 11 males and 13
females in response to the H1N1 (swine flu) virus vaccination. The specific antibody titer in serum was assayed by
the hemagglutination inhibition test on the days 5, 10, 17, and 52 following vaccination.
Results: In comparison to the sleep group, sleep-deprived males but not females had reduced serum
concentration of H1N1-specific antibodies five days after vaccination, whereas antibody titers at later time points
did not differ between the conditions.
Conclusions: These findings concur with the notion that sleep is a supportive influence in the very early stage of
an adaptive immune response to a viral antigen. However, our results do not support the view that acute sleep
deprivation has lasting effects on the human antibody titer response to influenza vaccination.
Background
The lack of time to sleep is a hallmark of modern living,
and it is commonly assumed that in the long run this
makes us unwell. This assumption is supported by
experimental data showing that acute sleep deprivation
decreases or decelerates the production of antigen- spe-
cific antibodies if sleep is interrupted in the night fol-
lowing the vaccination [1,2], indicating that poor sleep
patterns potentially counteract the process of effective
adaptive immune responses. Sleep is assumed to regu-
late immune function primarily by fostering adaptive
immune responses [3-5]. In the present study, we inves-
tigated a 7-week antibody titer in males and females in
r e s p o n s et oan o v e li n f l u e n z aAH 1 N 1v i r u s( s w i n ef l u )
vaccination and measured the effects of sleep in those
w h oh a das i n g l en i g h to fs l e e pd e p r i v a t i o nv e r s u sn o
sleep deprivation.
Results
Hemagglutination inhibition antibody titer against the
H1N1 virus
Overall, the antibody production did not differ between
treatments and/or sexes. (P ≥ 0.302 for all Kruskal-
Wallis comparisons, Figure 1AB). However, five days
after vaccination, the antibody response associated with
sleep deprivation was approximately 60% lower in males
than that measured in those of the sleep group (P ≤
0.050, two-tailed Mann-Whitney test; P ≤ 0.037 for the
Kruskal-Wallis comparison; Figure 1C). In contrast, the
immune response in women was generally not influ-
enced by sleep deprivation (P ≥ 0.171 for all Kruskal-
Wallis comparisons, Figure 1D).
Sleep
The EEG recordings revealed a normal sleep pattern (in
min ± SEM; Total sleep time: 470 ± 27; Slow-wave
sleep, 145 ± 14; Rapid-eye movement sleep, 81 ± 11).
Data gathered using sleep diaries (recording the time of
sleep) during the first 10 days after H1N1 vaccination
ensured the continuation of regular sleep start times (ie.,
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both conditions.
Discussion
Acute sleep deprivation impaired the early immune
response to H1N1 virus in males, despite prolonged per-
iods of sleep recovery after antigen exposure. In con-
trast, in females, the production of antibodies specific
for the swine flu virus was not influenced by sleep loss.
These results underline the relevance of sleep for sup-
porting immune functions [3-5].
Our results suggest that acute sleep deprivation is
associated with a delayed induction of adaptive immune
response to H1N1 virus in males that is consistent with
previous data. That is, interrupted sleep at the time of
first virus exposure is followed by a slower increase in
specific antibody titers relative to that following undis-
turbed sleep [1]. Factors important for an effective adap-
tive immune response show very concordant changes
under sleep deprivation [4,6]. For instance, the produc-
tion of growth hormone normally peaks during early
sleep periods [7], and this effect is suppressed by sleep
deprivation [8]. This hormone stimulates immune func-
tion directly in that many immune cells possess recep-
tors for growth hormone [9]. Further, the secretion of
cytokines involved in the adaptive immune response is
downregulated by sleep loss (e.g. Interleukin-2 and
Interleukin-7; [10,11]). Such hormonal changes asso-
ciated with interrupted sleep might have contributed to
the decelerated immune response to H1N1 that was
observed in males but not females in our study. Interest-
ingly, in a recently published study, a lipopolysacchar-
ide-induced immune response following acute sleep loss
has been shown to induce distinct sex differences inas-
much as sleep-deprived females showed increased pro-
duction of proinflammatory cytokines compared to
response in sleep-deprived males [12]. However, there
are also other candidate mechanisms that may account
for the impaired antibody titer response in sleep-
deprived males seen on day 5. For instance, compared
with sleep, sleep loss is associated with a striking
decrease in the number of myeloid dendritic cell precur-
sors [13]. These cells play a major role for the initiation
Figure 1 The effects of sleep compared with those of sleep
deprivation (SD) on the antibody titer in males and females in
response to the novel influenza A H1N1 virus vaccination. The
serum antibody response following the vaccination against H1N1
was assayed by the hemagglutination inhibition test (HAI) as
previously described (4). The higher the HAI value, the higher the
detectable serum antibody titer specific for H1N1 virus. A, antibody
response split by sleep (solid line, N = 13) vs. sleep deprivation
(dashed line, N = 11). B, antibody response split by females (solid
line, N = 13) vs. males (dashed line, N = 11). C, antibody response
in males split by sleep (solid line, N = 5) vs. sleep deprivation
(dashed line, N = 6). D, antibody response in females split by sleep
(solid line, N = 8) vs. sleep deprivation (dashed line, N = 5).
Differences between (sub)groups were analyzed using the Kruskal-
Wallis test, with Mann-Whitney U post hoc testing, and a P value ≤
0.05 was considered statistically significant. All data are presented as
means ± SEM.
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that the impaired effect of sleep loss on the early anti-
body titer response to the H1N1 vaccination was due to
a delayed migration of antibody titer producing B cells
into the blood.
At the first glance, the clinical relevance of our find-
ings is somewhat questionable because the only differ-
ence in specific antibody titers is 5 days after
vaccination in males only and titers even out thereafter,
which in the end results in same possible protection in
sleep deprived and regular sleep subjects. In contrast,
other studies with a similar study design showed pro-
found effects of sleep deprivation on specific antibody
titers at later time points, e.g. a 2-fold higher hepatitis A
titer at day 28 post immunization in regular sleep sub-
jects as compared to sleep deprived men [2]. Neverthe-
less, in a sort of external validation of our results,
previous observations revealed that partial sleep depriva-
tion in the time of vaccination against a seasonal influ-
enza virus induced differences in specific antibody titers
during early periods (ie., after 10 days) but not during
late periods (ie., after 28 days) of the adaptive immune
response [1]. One explanation for the discrepancy in
results among these studies could be that the effect size
of sleep deprivation on adaptive immune responses is
antigen- specific.
Limitations
Due to the similarity of the antigen with other influenza
strains there might be the possibility that the history of
influenza vaccination plays a profound role in the
response to H1N1 vaccine. In this respect, the major
shortcoming of the present study is that no HAI titers
were determined before vaccination to exclude possible
cross-reactivity of antibodies possibly already present.
Although it was vital that participants reported, in a
thorough interview, to have been free of major influ-
enza-like symptoms in the past 6 months, we thus can-
not exclude that there were any baseline differences in
HAI titers before vaccination. However, given the age of
the subjects (around 20 years) it is unlikely that they
had previously been exposed to a similar H1N1 until
the recent pandemic. Sleep deprivation did not influence
the antibody titer response to H1N1 in females. More-
over, there were no differences between the sleep and
sleep deprivation conditions in terms of circulating con-
centrations of H1N1 antibodies at time points later than
day 5. These negative findings should be interpreted
with caution inasmuch as they could be caused by the
low detection power associated with the relatively low
sample size of our study. Thus, these results indisputa-
bly require further validation in more studies. Finally,
although we obtained EEG measures in five subjects of
the sleep group, and thus quantitatively assured that
subjects did sleep, we cannot rule out that those whose
sleep were not recorded may have deviated from their
habitual sleep patterns. However, based on the sleep dia-
ries, all participants, including those who did not
undergo EEG recordings, did not report subjective dis-
turbances in their sleep habits.
Conclusions
Our results suggest that sleep deprivation in the night
after vaccination may influence very early phases of an
adaptive immune response, as indicated by the lower
antibody titer response in sleep-deprived males mea-
sured 5 days after vaccination against the H1N1 virus.
However, since antibody titers at later time points did
not differ between the sleep and sleep deprivation con-
ditions, our results do not support the view that acute
sleep deprivation has lasting effects on the human anti-
body titer response to influenza vaccination.
Methods
Subjects
24 healthy non-smoking students participated in the
experiment (born after 1986; body-mass- index, range
20-25 kg/m
2,T a b l e1 ) .T h e yw e r ea s s i g n e dt ot w o
groups: ‘sleep’ (n = 13; 5 males) or ‘sleep deprivation’ (n
= 11; 6 males). The groups did not differ in terms of
age or body weight. Acute illness was excluded by physi-
cal examination and routine laboratory investigation.
During an interview before the study, all participants
reported having a regular sleep-wake rhythm (i.e. parti-
cipants’ main sleep periods were between 10:00 PM and
8:00 AM the next morning; no shift work) and none
were taking medication (including analgesics such as
acetaminophen). Further, to be included in the study it
was vital that participants reported, in a thorough inter-
view, to have been free of major influenza-like symp-
toms in the past 6 months (e.g., high fever, chest
congestion, vomiting). The study was approved by the
Regional Ethical Review Board (EPN) in Uppsala, Swe-
den. All participants gave written informed consent and
were paid for enrolling in the study.
Experimental design and procedure
The experimental time schedule is presented in Table 2.
All subjects were vaccinated against swine flu (0.5-mL
intramuscular injection, Pandemrix, GlaxoSmithKline,
UK) at 7:30 AM on the morning of 27th November
2009. They were not informed about their respective
group assignment until 8:00 PM the same day. The elec-
troencephalography (EEG) off i v es t u d e n t so ft h es l e e p
group was continuously recorded in the night after vac-
cination using an ambulatory amplifier (Embla, Flaga hf,
Iceland), and polysomnography (including EMG and
EOG) was performed according to standard criteria [15].
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scorer blinded to the study hypothesis. The subjects in
the wake group remained in the sleep laboratory and
did not sleep until 6:00 PM the following day. To keep
subjects awake, they were provided with a selection of
movies, games, and books and were continuously
observed by investigators. Further, the lights were on
(~800 lux) and the subjects were provided with regular
meals. On the day of vaccination and the day after, stu-
dents of both conditions were not allowed to consume
caffeine-containing beverages.
Blood was sampled at ~8:00 AM in the morning on
days 5, 10, 17, and 52 after the vaccination and stored at
-80°C until assay. Hemagglutination inhibition (HAI)
antibody titers against the H1N1 virus were determined
in duplicate. Serum samples were treated with receptor-
destroying enzyme and then incubated at 56°C for 30
min. HAI assays were performed at a starting dilution of
1:10, with subsequent serial -fold dilutions (maximum
dilution level, 1:5120). A seroprotective titer for HAI was
defined as 1:40. Chicken erythrocytes (0.5%) were used
for the agglutination. All samples from a single partici-
pant were tested simultaneously and run in duplicate.
Statistical analysis
For statistical reasons, the dilution levels deriving from
hemagglutination inhibition (HAI) assay were trans-
formed into degrees of dilution. For instance, a HAI
dilution level of 1:10 corresponds a degree of dilution of
1 (maximum dilution level, 1:5120 = degree of dilution
of 10). Differences between groups were analyzed using
Kruskal-Wallis nonparametric analysis with Mann-Whit-
ney U post hoc testing, and a P value ≤ 0.05 was consid-
ered statistically significant. Treatment effects were also
evaluated separately for the male and female subgroups.
All data are presented as means ± SEM.
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Table 1 Subjective data
Sleep
group
Sleep deprivation
group
Number of subjects All 13 11
Women 8 5
Men 5 6
Age (in years) All 20.6 ± 0.4 20.4 ± 0.5
Women 21.5 ± 0.4 20.2 ± 0.7
Men 19.2 ± 0.4 20.5 ± 0.7
Body weight (in kg) All 65.4 ± 4.9 64.6 ± 5.7
Women 56.9 ± 6.0 50.2 ± 7.6
C-reactive Protein
(mg/L)
Men 79.0 ± 3.7 76.7 ± 4.2
All 0.98 ± 0.26 1.22 ± 0.32
Women 0.97 ± 0.25 1.21 ± 0.38
Ig G (g/L) Men 0.99 ± 0.60 1.24 ± 0.53
All 10.61 ±
0.63
10.5 ± 0.41
Women 10.61 ±
0.85
10.56 ± 0.70
Ig A (g/L) Men 10.60 ±
1.04
10.38 ± 0.53
All 1.99 ± 0.25 2.10 ± 0.41
Women 1.82 ± 0.23 2.13 ± 0.39
Men 2.28 ± 0.23 2.07 ± 0.55
Ig M (g/L) All 1.30 ± 0.16 1.22 ± 0.18
Women 1.46 ± 0.23 1.54 ± 0.29
Men 1.05 ± 0.16 0.96 ± 0.18
All variables are presented with mean ± S.E.M. Three days before vaccination,
circulating levels of C-reactive protein and immunglobulin subclasses (A, G, M)
were analyzed by normal laboratory routine. No statistical differences were
found between the groups (assessed by Mann-Whitney-U-tests).
Table 2 Experimental time schedule.
Experimental day Date Measurements
Day -3 2009-11-24 Health assessment
Day 0 2009-11-27 H1N1 vaccination
2009-11-28 Sleep diary
2009-11-29 Sleep diary
2009-11-30 Sleep diary
2009-12-01 Sleep diary
Day 5 2009-12-02 Sleep diary & Serum antibody titer
2009-12-03 Sleep diary
2009-12-04 Sleep diary
2009-12-05 Sleep diary
2009-12-06 Sleep diary
Day 10 2009-12-07 Sleep diary & Serum antibody titer
Day 17 2009-12-14 Serum antibody titer
Day 52 2010-01-18 Serum antibody titer
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